1. Home
  2. SLE vs RDHL Comparison

SLE vs RDHL Comparison

Compare SLE & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Super League Enterprise Inc.

SLE

Super League Enterprise Inc.

HOLD

Current Price

$3.15

Market Cap

5.0M

ML Signal

HOLD

Logo Redhill Biopharma Ltd.

RDHL

Redhill Biopharma Ltd.

HOLD

Current Price

$0.93

Market Cap

5.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLE
RDHL
Founded
2014
2009
Country
United States
Israel
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
5.4M
IPO Year
2019
2012

Fundamental Metrics

Financial Performance
Metric
SLE
RDHL
Price
$3.15
$0.93
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$60.00
N/A
AVG Volume (30 Days)
49.3K
160.2K
Earning Date
05-14-2026
04-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,064,000.00
N/A
Revenue This Year
$24.86
$381.91
Revenue Next Year
$49.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
90.41
N/A
52 Week Low
$0.48
$0.71
52 Week High
$11.43
$3.31

Technical Indicators

Market Signals
Indicator
SLE
RDHL
Relative Strength Index (RSI) 40.47 48.17
Support Level $0.51 $0.76
Resistance Level $3.43 $1.07
Average True Range (ATR) 0.25 0.09
MACD -0.02 -0.01
Stochastic Oscillator 29.03 39.42

Price Performance

Historical Comparison
SLE
RDHL

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

Share on Social Networks: